Representative Image
Representative Image

Researchers find increased cardiovascular response to nitroglycerin injection in migraine patients

ANI | Updated: Dec 28, 2019 11:13 IST

London [UK], Dec 28 (ANI): Researchers have found an increased cardiovascular response in migraine patients to nitroglycerin injection, indicating a greater systemic vulnerability in them to this compound. In fact, nitroglycerin has been shown to be a strong migraine-provoking compound in previous studies.
A clinical investigation published in the journal 'Cephalalgia', the official journal of the International Headache Society, suggested that migraine patients may exhibit a systemic pathophysiological alteration.
The study, entitled "Abnormal cardiovascular response to nitroglycerin in migraine", was conducted by Dr Willebrordus PJ van Oosterhout, from Leiden University Medical Centre, Department of Neurology, Leiden, The Netherlands.
Nitroglycerine (NTG) is known to induce migraine attacks in migraine patients. Because of its vasodilating properties, NTG is used in cardiovascular research to test cardiovascular adjustments in the face of changes in blood pressure secondary to blood venous pooling.
For example, NTG is used to test baroreflex function in individuals with vasovagal syncope, which is more common in migraine patients.
Dr van Oosterhout and colleagues assessed cardiovascular parameters through photoplethysmography before (-10 min.), during the infusion of NTG intravenously (20 min.), and after the NTG infusion (10 min.)
They compared differences between migraine patients who had NTG-triggered attacks and healthy people. The presence of vasovagal syncope was assessed as well.
Ten healthy participants and 16 migraine patients were included in the study. Thirteen out of 16 patients (81.3 per cent) had migraine attacks following NTG infusion, against none from the control group. No vasovagal syncope was provoked.
Migraine patients showed higher heart rate response to NTG infusion. In a subgroup analysis with migraine patients group split into patients with early-onset attacks (those whose attacks occurred < 270 min after NTG infusion) or with late-onset attacks (> 270 min.), stroke volume and cardiac output were reduced in both migraine groups compared to healthy control group, with more pronounced reductions in the early-onset migraine attacks group.
The authors' interpretations of these data are cautious, as the study was underpowered with a small sample.
Dr Oosterhout said: "The enhanced response of the systemic circulation to nitroglycerin in migraineurs suggests that the systemic vasculature is more susceptible to its effects. Sensitivity to nitric oxide (NO) may be enhanced, possibly due to higher perivascular concentrations of NO synthase."
Eventually, although there was no vasovagal syncope among participants, they don't rule out a specific vulnerability to migraine and vasovagal syncope attacks because some of the patients had also had a vasovagal syncope in their lives in this research. (ANI)